Line Plot from Scientific Research

Mixed effect regression modelling of the effect of felzartamab on IRRAT30 molecular injury scores. The thin solid lines represent individual patient trajectories for placebo (black) and felzartamab-treated patients (red). The thin dotted line depicts patient 9. The thick solid lines represent the predicted score by linear mixed-effects model fit with an interaction term between the score and time, including time and patient as random effects (FDR IRRAT30 0.0546). The shaded regions depict 95% confidence intervals for predicted scores.

DOI